Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties

Zyflamend, a blend of herbal extracts, effectively inhibits tumor growth using preclinical models of castrate-resistant prostate cancer mediated in part by 5 ′-adenosine monophosphate-activated protein kinase (...

Source: BMC Complementary and Alternative Medicine - June 18, 2018 Category: Complementary Medicine Authors: Amber F. MacDonald, Ahmed Bettaieb, Dallas R. Donohoe, Dina S. Alani, Anna Han, Yi Zhao and Jay Whelan Tags: Research article Source Type: research